# Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

> **NCT07413809** · PHASE3 · RECRUITING · sponsor: **The Affiliated People's Hospital of Ningbo University** · enrollment: 92 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Fosaprepitant
- **DRUG:** Fosaprepitant
- **DRUG:** Tropisetron
- **DRUG:** Olanzapine
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT07413809
- **Lead sponsor:** The Affiliated People's Hospital of Ningbo University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07413809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07413809, "Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07413809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*